AMLX logo

Amylyx Pharmaceuticals, Inc. (AMLX) Retained earnings

annual retained earnings:

-$606.69M-$301.74M(-98.95%)
December 31, 2024

Summary

  • As of today (September 18, 2025), AMLX annual retained earnings is -$606.69 million, with the most recent change of -$301.74 million (-98.95%) on December 31, 2024.
  • During the last 3 years, AMLX annual retained earnings has fallen by -$450.85 million (-289.29%).
  • AMLX annual retained earnings is now -2266.75% below its all-time high of -$25.63 million, reached on December 31, 2019.

Performance

AMLX Retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

quarterly retained earnings:

-$684.04M-$41.44M(-6.45%)
June 1, 2025

Summary

  • As of today (September 18, 2025), AMLX quarterly retained earnings is -$684.04 million, with the most recent change of -$41.44 million (-6.45%) on June 1, 2025.
  • Over the past year, AMLX quarterly retained earnings has dropped by -$187.60 million (-37.79%).
  • AMLX quarterly retained earnings is now -907.22% below its all-time high of -$67.91 million, reached on December 31, 2020.

Performance

AMLX quarterly retained earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAMLXbalance sheet metrics

Retained earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

AMLX Retained earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-99.0%-37.8%
3 y3 years-289.3%-165.4%
5 y5 years-2266.8%-907.2%

AMLX Retained earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-289.3%at low-165.4%at low
5 y5-year-2266.8%at low-907.2%at low
alltimeall time-2266.8%at low-907.2%at low

AMLX Retained earnings History

DateAnnualQuarterly
Jun 2025
-
-$684.04M(+6.4%)
Mar 2025
-
-$642.60M(+5.9%)
Dec 2024
-$606.69M(+98.9%)
-$606.69M(+6.6%)
Sep 2024
-
-$569.15M(+14.6%)
Jun 2024
-
-$496.44M(+17.2%)
Mar 2024
-
-$423.74M(+39.0%)
Dec 2023
-$304.95M
-$304.95M(-1.5%)
Sep 2023
-
-$309.68M(-6.3%)
DateAnnualQuarterly
Jun 2023
-
-$330.57M(-6.3%)
Mar 2023
-
-$352.65M(-0.4%)
Dec 2022
-$354.22M(+127.3%)
-$354.22M(+13.7%)
Sep 2022
-
-$311.52M(+20.9%)
Jun 2022
-
-$257.76M(+26.5%)
Mar 2022
-
-$203.69M(+30.7%)
Dec 2021
-$155.84M(+129.5%)
-$155.84M(+129.5%)
Dec 2020
-$67.91M(+164.9%)
-$67.91M
Dec 2019
-$25.63M
-

FAQ

  • What is Amylyx Pharmaceuticals, Inc. annual retained earnings?
  • What is the all time high annual retained earnings for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. annual retained earnings year-on-year change?
  • What is Amylyx Pharmaceuticals, Inc. quarterly retained earnings?
  • What is the all time high quarterly retained earnings for Amylyx Pharmaceuticals, Inc.?
  • What is Amylyx Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?

What is Amylyx Pharmaceuticals, Inc. annual retained earnings?

The current annual retained earnings of AMLX is -$606.69M

What is the all time high annual retained earnings for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high annual retained earnings is -$25.63M

What is Amylyx Pharmaceuticals, Inc. annual retained earnings year-on-year change?

Over the past year, AMLX annual retained earnings has changed by -$301.74M (-98.95%)

What is Amylyx Pharmaceuticals, Inc. quarterly retained earnings?

The current quarterly retained earnings of AMLX is -$684.04M

What is the all time high quarterly retained earnings for Amylyx Pharmaceuticals, Inc.?

Amylyx Pharmaceuticals, Inc. all-time high quarterly retained earnings is -$67.91M

What is Amylyx Pharmaceuticals, Inc. quarterly retained earnings year-on-year change?

Over the past year, AMLX quarterly retained earnings has changed by -$187.60M (-37.79%)
On this page